Salary Range:CHF142,100.00 - CHF263,900.00 Job Description SummaryAs a Cardiovascular and Metabolism (CVM) Therapeutic Area Biomarker Lead (TABL) (Director) you will lead the CVM disease area biomarker matrix team and be responsible for the development and implementation
Company Description Sobi is an international biopharmaceutical company, dedicated to providing access to innovative treatments that transform life for people with rare diseases in the areas of haematology, immunology and specialty care. With our head office
Company Description Sobi is an international biopharmaceutical company, dedicated to providing access to innovative treatments that transform life for people with rare diseases in the areas of haematology, immunology and specialty care. With our head office
Salary Range:CHF 0.00 - CHF 0.00 Job Description SummaryThis postdoctoral fellowship offers a unique opportunity to advance the use of artificial intelligence and machine learning for chemical synthesis and reactivity prediction in drug discovery. The successful
Salary Range:CHF142,100.00 - CHF263,900.00 Job Description SummaryDirector, Strategic Projects Lead #LI-Hybrid Location: Basel, Switzerland This role is based in Basel, Switzerland. Novartis is unable to offer relocation support for this role. Please only apply if this
Overview As Quantitative Risk Analyst in BIS’s Risk Models team, you will help design, implement, and calibrate models that measure risk and value the balance sheet. You will work with cross-functional colleagues to keep models aligned with
Overview In this role you apply behavioural science and rigorous evaluation to design and pilot anti-corruption interventions. You will lead impact evaluations, including randomized trials, and analyse data to build robust evidence of what works. You
Overview In this role, you will advance quantitative imaging science to translate complex data into actionable insights for clinical development. You will join the Imaging Data Insights Basel team to shape data-driven biomarker strategies and inform portfolio
1 out of 10 people are diagnosed with an autoimmune or autoinflammatory disease. This is why the Autoimmunity, Transplantation & Inflammation (ATI) Disease Area group at the Novartis Institutes for Biomedical Research (NIBR) is investing in